HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro activity of RBx 7644 (ranbezolid) on biofilm producing bacteria.

Abstract
Biofilm associated infections are becoming more common. Treatment outcome of device related infections cannot be predicted by the results of a standard susceptibility test such as the MIC. Microorganisms involved in device related infections have a slow growth rate and adhere to surfaces. Activity against glass adherent bacteria has been shown to be correlated with treatment outcome in animal models of catheter related infections. Drug efficacy can be predicted if glass adherent staphylococci are killed by low drug concentration. The eradication of bacteria adhering to glass beads and inhibition of biofilm formation by ranbezolid and three other antibiotics (quinupristin/dalfopristin, vancomycin and linezolid) was studied. The results indicated that ranbezolid required only (2-4 x MIC) for total clearance of glass-adherent MRSA 562 and MRSE 879, compared with vancomycin (8 x), quinupristin/dalfopristin (1-4 x) and linezolid (4-16 x MIC). In addition ranbezolid inhibited biofilm formation to a greater extent at sub MIC and MIC level. In conclusion, this study indicated that ranbezolid had potent activity against adherent staphylococci isolates and may prove useful in the prevention and treatment of device related infections caused by staphylococci.
AuthorsTarun Mathur, Pragya Bhateja, Manisha Pandya, Tasneem Fatma, Ashok Rattan
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 24 Issue 4 Pg. 369-73 (Oct 2004) ISSN: 0924-8579 [Print] Netherlands
PMID15380263 (Publication Type: Journal Article)
Chemical References
  • Anti-Infective Agents
  • Furans
  • Oxazoles
  • ranbezolid
Topics
  • Anti-Infective Agents (pharmacology)
  • Bacterial Adhesion (drug effects)
  • Biofilms (drug effects)
  • Drug Resistance, Bacterial
  • Drug Resistance, Multiple
  • Furans (pharmacology)
  • Humans
  • Microbial Sensitivity Tests
  • Oxazoles (pharmacology)
  • Staphylococcus aureus (drug effects)
  • Staphylococcus epidermidis (drug effects, isolation & purification)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: